The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA5209464
Max Phase: Preclinical
Molecular Formula: C22H23N3O4
Molecular Weight: 393.44
Associated Items:
Representations Canonical SMILES: CCCCCOc1ccc(NC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2)cc1
Standard InChI: InChI=1S/C22H23N3O4/c1-2-3-4-11-27-17-8-6-16(7-9-17)23-22-24-18(21(26)25-22)12-15-5-10-19-20(13-15)29-14-28-19/h5-10,12-13H,2-4,11,14H2,1H3,(H2,23,24,25,26)/b18-12-
Standard InChI Key: BNEMOONNXBNRSX-PDGQHHTCSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 393.44Molecular Weight (Monoisotopic): 393.1689AlogP: 3.92#Rotatable Bonds: 7Polar Surface Area: 81.18Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0CX Acidic pKa: 9.87CX Basic pKa: 0.34CX LogP: 4.17CX LogD: 4.16Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.55Np Likeness Score: -0.45
References 1. Tahtouh T, Durieu E, Villiers B, Bruyère C, Nguyen TL, Fant X, Ahn KH, Khurana L, Deau E, Lindberg MF, Sévère E, Miege F, Roche D, Limanton E, L'Helgoual'ch JM, Burgy G, Guiheneuf S, Herault Y, Kendall DA, Carreaux F, Bazureau JP, Meijer L.. (2022) Structure-Activity Relationship in the Leucettine Family of Kinase Inhibitors., 65 (2.0): [PMID:34928152 ] [10.1021/acs.jmedchem.1c01141 ]